Department of Radiation Oncology, Washington University School of Medicine, Campus Box 8224, St. Louis, MO 63110, USA.
Eur J Nucl Med Mol Imaging. 2013 May;40(5):716-27. doi: 10.1007/s00259-012-2332-4. Epub 2013 Jan 23.
The aim of this pilot study was to explore heterogeneity in the temporal behavior of intratumoral [(18)F]fluorodeoxyglucose (FDG) accumulation at a regional scale in patients with cervical cancer undergoing chemoradiotherapy.
Included in the study were 20 patients with FIGO stages IB1 to IVA cervical cancer treated with combined chemoradiotherapy. Patients underwent FDG PET/CT before treatment, during weeks 2 and 4 of treatment, and 12 weeks after completion of therapy. Patients were classified based on response to therapy as showing a complete metabolic response (CMR), a partial metabolic response (PMR), or residual disease and the development of new disease (NEW). Based on the presence of residual primary tumor following therapy, patients were divided into two groups, CMR and PMR/NEW. Temporal profiles of intratumoral FDG heterogeneity as characterized by textural features at a regional scale were assessed and compared with those of the standardized uptake value (SUV) indices (SUVmax and SUVmean) within the context of differentiating response groups.
Textural features at a regional scale with emphasis on characterizing contiguous regions of high uptake in tumors decreased significantly with time (P < 0.001) in the CMR group, while features describing contiguous regions of low uptake along with those measuring the nonuniformity of contiguous isointense regions in tumors exhibited significant temporal changes in the PMR/NEW group (P < 0.03) but showed no persistent trends with time. Both SUV indices showed significant changes during the course of the disease in both patient groups (P < 0.001 for SUVmax and SUVmean in the CMR group; P = 0.0109 and 0.0136, respectively, for SUVmax and SUVmean in the PMR/NEW group), and also decreased at a constant rate in the CMR group and decreased up to the 4th week of treatment and then increased in the PMR/NEW group.
The temporal changes in the heterogeneity of intratumoral FDG distribution characterized at a regional scale using image-based textural features may provide an adjunctive or alternative option for understanding tumor response to chemoradiotherapy and interpreting FDG accumulation dynamics in patients with malignant cervical tumors during the course of the disease.
本研究旨在探索宫颈癌患者放化疗过程中肿瘤内[¹⁸F]氟脱氧葡萄糖(FDG)摄取的区域性时间异质性。
本研究纳入 20 例接受放化疗的FIGO 分期 IB1 至 IVA 期宫颈癌患者。患者在治疗前、治疗第 2 周和第 4 周以及治疗结束后 12 周行 FDG PET/CT 检查。根据治疗反应,患者分为完全代谢缓解(CMR)、部分代谢缓解(PMR)或残留疾病和新发疾病(NEW)。根据治疗后原发肿瘤的残留情况,将患者分为 CMR 和 PMR/NEW 两组。评估并比较肿瘤内区域性异质性的纹理特征的时间变化,这些特征由文本特征描述,以区分反应组,并与标准化摄取值(SUV)指数(SUVmax 和 SUVmean)进行比较。
CMR 组中,强调肿瘤内高摄取连续区域特征的区域性纹理特征随时间显著降低(P < 0.001),而 PMR/NEW 组中描述肿瘤内低摄取连续区域的特征以及测量肿瘤内等强度连续区域非均匀性的特征随时间发生显著变化(P < 0.03),但没有随时间持续的趋势。SUV 指数在两组患者的疾病过程中均发生显著变化(CMR 组中 SUVmax 和 SUVmean 的 P < 0.001;PMR/NEW 组中 SUVmax 和 SUVmean 的 P = 0.0109 和 0.0136),并且在 CMR 组中以恒定的速率下降,在 PMR/NEW 组中在治疗的第 4 周之前下降,然后增加。
使用基于图像的纹理特征描述的肿瘤内 FDG 分布异质性的时间变化可能为理解宫颈癌患者放化疗反应以及在疾病过程中解释恶性宫颈肿瘤的 FDG 摄取动力学提供一种补充或替代选择。